Hyperglycemia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Hyperglycemia Clinical Trial Report Overview
A total of 506 hyperglycemia clinical trials were conducted as of March 2024. The hyperglycemia clinical trial report provides a comprehensive understanding of the hyperglycemia clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials.
Key Regions | · North America
· Europe · Asia-Pacific · Middle East and Africa · South and Central America |
Key Countries | · The US
· China · Japan · Australia · Iran |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Sanofi
· Novo Holdings AS · Eli Lilly and Co · Merck & Co Inc · Novartis AG |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Hyperglycemia Clinical Trials Segmentation by Regions and Countries
As of March 2024, Asia-Pacific led the hyperglycemia clinical trials landscape with more than 34% of the clinical trials conducted there
The key regions considered for hyperglycemia clinical trials analysis are North America, Europe, Asia-Pacific, the Middle East and Africa, and South and Central America.
In the country-wise analysis, the US had the highest number of hyperglycemia clinical trials as of March 2024. The UK had the highest average patient enrollment in hyperglycemia clinical trials during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the US held the highest proportion of Hyperglycemia to Metabolic Disorders clinical trials as of March 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Indonesia held the highest proportion of Hyperglycemia to Metabolic Disorders clinical trials as of March 2024.
Hyperglycemia Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Hyperglycemia Clinical Trials
Hyperglycemia Clinical Trials Segmentation by Sponsor Types
The key sponsor types for hyperglycemia clinical trials are company, institution, and the government. As of March 2024, the institution sponsor type conducted more than 67% of hyperglycemia clinical trials.
Hyperglycemia Clinical Trials Analysis by Sponsor Types, 2024 (%)
Buy the Full Report for More Sponsor Type Insights into the Hyperglycemia Clinical Trials
Hyperglycemia Clinical Trials - Competitive Landscape
In 2024, Sanofi conducted the highest number of hyperglycemia clinical trials
A few of the leading sponsors for hyperglycemia clinical trials are:
- Sanofi
- Novo Holdings AS
- Eli Lilly and Co
- Merck & Co Inc
- Novartis AG
Hyperglycemia Clinical Trials Analysis by Sponsors, 2024 (%)
Buy the Full Report to Know More about the Leading Sponsors of Hyperglycemia Clinical Trials
Segments Covered in the Report
Hyperglycemia Clinical Trials Regional Outlook (2024)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South and Central America
Hyperglycemia Clinical Trials Country Outlook (2024)
- The US
- China
- Japan
- Australia
- Iran
Hyperglycemia Clinical Trials Sponsor Type Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulate key business strategies with regard to investment.
- Identify prominent locations for conducting clinical trials which saves time and cost.
- Get top-level analysis of the global clinical trials market which helps in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand clinical trial assessment of the indication on a global, regional, and country level.
Novo Holdings AS
Eli Lilly and Co
Merck & Co Inc
Novartis AG
AstraZeneca Plc
Bristol-Myers Squibb Co
Medtronic Plc
Advance Pharmaceutical Co Ltd
C. H. Boehringer Sohn AG & Co KG
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of hyperglycemia clinical trials in March 2024?
North America accounted for the highest number of hyperglycemia clinical trials as of March 2024.
-
Which country conducted the highest number of hyperglycemia clinical trials in March 2024?
The US conducted the highest number of hyperglycemia clinical trials as of March 2024.
-
Which sponsor type was the most prominent in the hyperglycemia clinical trials in March 2024?
As of March 2024, institution conducted most of the hyperglycemia clinical trials.
-
Which are the leading sponsors of hyperglycemia clinical trials?
A few of the leading sponsors of hyperglycemia clinical trials are Sanofi, Novo Holdings AS, Eli Lilly and Co, Merck & Co Inc, and Novartis AG, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.